JP Patent

JP7480261B2 — 片頭痛の処置における使用のためのラスミジタンとｃｇｒｐアンタゴニストとの併用療法

Assigned to イーライ リリー アンド カンパニー · Expires 2024-05-09 · 2y expired

What this patent protects

Patent listed against Qulipta.

Drugs covered by this patent

Patent Metadata

Patent number
JP7480261B2
Jurisdiction
JP
Classification
—
Expires
2024-05-09
Drug substance claim
No
Drug product claim
No
Assignee
イーライ リリー アンド カンパニー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.